An invalid vocabulary is selected. Please change it in the options.
Title Creditssort descending Start date - Expiration date
Updates in the Management of CLL: Histologic Transformation and Relapsed/Refractory Disease 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Updates to Front-line Therapy in Hodgkin Lymphoma 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Strategies to Identify Needs and Coordinate Referrals to a Multidisciplinary Chronic Graft-Versus-Host Disease Clinic 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Keynote Session: CAR T-cell Therapy - Historical Perspectives and Major Milestones 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Keynote Session: CAR T-cell Therapy - Focus on Lymphomas 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Prognostic Significance of Mutations in Myeloproliferative Neoplasms 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Current Approaches to Initial Treatment of Newly Diagnosed Multiple Myeloma 0.52 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Biomarker Testing for Immunotherapy 0.52 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
New Therapies for Ovarian Cancer 0.53 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
Screening for Distress in Cancer: Implementing the Standard of Care 0.54 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
Emerging Options for the Management of Relapsed/Refractory Hodgkin Lymphoma 0.54 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Optimizing TKI Therapy for Chronic Phase CML: Sequencing of TKI Therapy and Treatment-free Remission 0.54 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Consideration for Use of Novel Agents in Acute Myeloid Leukemia 0.55 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
NCCN Guidelines® Updates: Treatment of Pancreatic Cancer 0.56 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
Implementation and Implications of AJCC Cancer Staging Manual, 8th Edition for Breast Cancer Staging 0.56 03/18/2019 - 12:00am to 03/18/2020 - 12:00am

Pages